MIM
GRDN

MetLife Investment Management’s Guardian Pharmacy Services GRDN Stock Holding History

MetLife Investment Management’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$470K Buy
12,472
+620
+5% +$20.3K ﹤0.01% 1784
2025
Q4 		$357K Buy
11,852
+109
+0.9% +$3.08K ﹤0.01% 1955
2025
Q3 		$308K Buy
11,743
+3,740
+47% +$89.1K ﹤0.01% 2066
2025
Q2 		$171K Buy
8,003
+2,391
+43% +$54K ﹤0.01% 2270
2025
Q1 		$119K Hold
5,612
– – ﹤0.01% 2448
2024
Q4 		$114K Buy
+5,612
New +$116K ﹤0.01% 2565

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

MetLife Investment Management's GRDN Position: Q1 2026 in Review

MetLife Investment Management increased its Guardian Pharmacy Services (GRDN) stake by 5.2% in Q1 2026, buying an estimated $20.3K and bringing the position to 12,472 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #1784.

MetLife Investment Management first reported a position in GRDN in Q4 2024 and has held it in 6 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • MetLife Investment Management held 12,472 shares of Guardian Pharmacy Services worth $470K as of Q1 2026.
  • MetLife Investment Management bought 620 Guardian Pharmacy Services shares in Q1 2026, an estimated $20.3K.
  • Guardian Pharmacy Services made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1784 holding.
  • MetLife Investment Management first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 6 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.